Free Trial

Carmell (CTCX) Competitors

Carmell logo
$2.45 -0.07 (-2.78%)
As of 07/1/2025

CTCX vs. PROF, INGN, ELMD, KRMD, CVRX, AVR, LNSR, PDEX, PTHL, and LAKE

Should you be buying Carmell stock or one of its competitors? The main competitors of Carmell include Profound Medical (PROF), Inogen (INGN), Electromed (ELMD), KORU Medical Systems (KRMD), CVRx (CVRX), Anteris Technologies Global (AVR), LENSAR (LNSR), Pro-Dex (PDEX), Pheton (PTHL), and Lakeland Industries (LAKE). These companies are all part of the "medical equipment" industry.

Carmell vs. Its Competitors

Profound Medical (NASDAQ:PROF) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, earnings, risk, profitability, analyst recommendations, institutional ownership, media sentiment and dividends.

47.9% of Profound Medical shares are owned by institutional investors. Comparatively, 24.2% of Carmell shares are owned by institutional investors. 1.5% of Profound Medical shares are owned by company insiders. Comparatively, 29.0% of Carmell shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Profound Medical had 1 more articles in the media than Carmell. MarketBeat recorded 1 mentions for Profound Medical and 0 mentions for Carmell. Profound Medical's average media sentiment score of 0.75 beat Carmell's score of 0.00 indicating that Profound Medical is being referred to more favorably in the media.

Company Overall Sentiment
Profound Medical Positive
Carmell Neutral

Carmell has lower revenue, but higher earnings than Profound Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Profound Medical$10.68M16.83-$27.82M-$1.22-4.90
Carmell$32.84K1,559.65-$15.44MN/AN/A

Profound Medical currently has a consensus target price of $11.50, suggesting a potential upside of 92.31%. Given Profound Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Profound Medical is more favorable than Carmell.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Profound Medical
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Carmell
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Profound Medical has a beta of 0.49, suggesting that its share price is 51% less volatile than the S&P 500. Comparatively, Carmell has a beta of 0.51, suggesting that its share price is 49% less volatile than the S&P 500.

Carmell has a net margin of 0.00% compared to Profound Medical's net margin of -269.35%. Profound Medical's return on equity of -70.41% beat Carmell's return on equity.

Company Net Margins Return on Equity Return on Assets
Profound Medical-269.35% -70.41% -57.22%
Carmell N/A -217.50%-50.22%

Summary

Profound Medical beats Carmell on 8 of the 14 factors compared between the two stocks.

Get Carmell News Delivered to You Automatically

Sign up to receive the latest news and ratings for CTCX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CTCX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CTCX vs. The Competition

MetricCarmellSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$51.22M$248.27M$5.50B$9.01B
Dividend YieldN/AN/A5.39%4.11%
P/E RatioN/A5.9127.4220.07
Price / Sales1,559.6570.57398.50109.13
Price / CashN/A196.1236.1356.90
Price / Book2.296.138.015.70
Net Income-$15.44M-$26.71M$3.16B$248.47M
7 Day Performance-4.67%-1.78%2.08%2.92%
1 Month Performance-25.08%-6.36%4.38%5.77%
1 Year Performance40.80%24.49%35.81%21.39%

Carmell Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CTCX
Carmell
N/A$2.45
-2.8%
N/A+36.1%$51.22M$32.84K0.0014Gap Down
PROF
Profound Medical
2.5007 of 5 stars
$6.29
+4.7%
$11.50
+82.7%
-29.0%$189.03M$11.86M-5.16150
INGN
Inogen
4.3148 of 5 stars
$6.95
+4.1%
$11.00
+58.4%
-3.3%$186.75M$335.70M-6.041,030Positive News
ELMD
Electromed
1.227 of 5 stars
$21.53
+1.3%
$38.00
+76.5%
+45.1%$180.51M$61.44M28.70160
KRMD
KORU Medical Systems
2.2435 of 5 stars
$3.57
+3.9%
$4.50
+26.2%
+60.4%$164.72M$33.65M-32.4580Positive News
CVRX
CVRx
2.769 of 5 stars
$5.84
+2.1%
$14.50
+148.3%
-45.2%$152.12M$51.29M-2.68160Positive News
AVR
Anteris Technologies Global
N/A$4.06
+6.8%
$16.50
+306.4%
N/A$146.40M$2.70M0.00138News Coverage
LNSR
LENSAR
1.3009 of 5 stars
$12.39
+1.2%
$15.00
+21.1%
+203.7%$146.10M$57.07M-2.55110
PDEX
Pro-Dex
2.2489 of 5 stars
$42.17
+0.8%
$56.00
+32.8%
+151.3%$137.46M$53.84M15.06140
PTHL
Pheton
N/A$20.18
+1.9%
N/AN/A$132.78M$448.20K0.0011
LAKE
Lakeland Industries
4.8736 of 5 stars
$13.76
-1.9%
$26.00
+88.9%
-39.0%$131.33M$167.21M-4.592,100Positive News

Related Companies and Tools


This page (NASDAQ:CTCX) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners